Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Alati

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cancers|January 11, 2024
Venetoclax: A Game Changer in the Treatment of Younger AML Patients?Matteo Molica, Salvatore Perrone, Vincenzo Federico, et al.
Transfusion|March 17, 2010
Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patientsEsther Natalie Oliva, Francesca Ronco, Antonio Marino, et al.
International Journal of Molecular Sciences|March 6, 2021
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic LeukemiaMassimo Martino, Caterina Alati, Filippo Antonio Canale, et al.
Cancers|October 16, 2025
The Evolving Role of Hematopoietic Stem Cell Transplantation in Philadelphia-like Acute Lymphoblastic Leukemia: From High-Risk Standard to Precision StrategiesMatteo Molica, Claudia Simio, Laura De Fazio, et al.
Cancers|December 11, 2025
Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and BeyondMatteo Molica, Claudia Simio, Laura De Fazio, et al.
Journal of Clinical Medicine|June 26, 2026
Targeted Therapies Combined with Intensive Chemotherapy in Fit Acute Myeloid Leukemia: Past Developments, Current Evidence, and Future Therapeutic ParadigmsMatteo Molica, Laura De Fazio, Claudia Simio, et al.
Expert Review of Hematology|March 28, 2026
Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timingMatteo Molica, Laura De Fazio, Ferdinando Porretto, et al.
Genes|September 28, 2023
The Role of MicroRNA in Graft-Versus-Host-Disease: A ReviewMartina Pitea, Filippo Antonio Canale, Gaetana Porto, et al.
Journal of Diabetes|July 26, 2014
Erythropoietin treatment in patients with myelodysplastic syndromes and type 2 diabetesRoberto Latagliata, Caterina Alati, Ida Carmosino, et al.
Expert Opinion on Biological Therapy|December 11, 2023
Integrating CAR-T cell therapy into the management of DLBCL: what we are learningMassimo Martino, Filippo Antonio Canale, Gaetana Porto, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cancers|January 11, 2024
Venetoclax: A Game Changer in the Treatment of Younger AML Patients?Matteo Molica, Salvatore Perrone, Vincenzo Federico, et al.
Transfusion|March 17, 2010
Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patientsEsther Natalie Oliva, Francesca Ronco, Antonio Marino, et al.
International Journal of Molecular Sciences|March 6, 2021
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic LeukemiaMassimo Martino, Caterina Alati, Filippo Antonio Canale, et al.
Cancers|October 16, 2025
The Evolving Role of Hematopoietic Stem Cell Transplantation in Philadelphia-like Acute Lymphoblastic Leukemia: From High-Risk Standard to Precision StrategiesMatteo Molica, Claudia Simio, Laura De Fazio, et al.
Cancers|December 11, 2025
Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and BeyondMatteo Molica, Claudia Simio, Laura De Fazio, et al.
Journal of Clinical Medicine|June 26, 2026
Targeted Therapies Combined with Intensive Chemotherapy in Fit Acute Myeloid Leukemia: Past Developments, Current Evidence, and Future Therapeutic ParadigmsMatteo Molica, Laura De Fazio, Claudia Simio, et al.
Expert Review of Hematology|March 28, 2026
Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timingMatteo Molica, Laura De Fazio, Ferdinando Porretto, et al.
Genes|September 28, 2023
The Role of MicroRNA in Graft-Versus-Host-Disease: A ReviewMartina Pitea, Filippo Antonio Canale, Gaetana Porto, et al.
Journal of Diabetes|July 26, 2014
Erythropoietin treatment in patients with myelodysplastic syndromes and type 2 diabetesRoberto Latagliata, Caterina Alati, Ida Carmosino, et al.
Expert Opinion on Biological Therapy|December 11, 2023
Integrating CAR-T cell therapy into the management of DLBCL: what we are learningMassimo Martino, Filippo Antonio Canale, Gaetana Porto, et al.
Pageof 5